Neoadjuvant Stereotactic Ablative Radiotherapy Before Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma

Дата публикации: 15-10-2026 00:00:00

This phase 2 nonrandomized clinical trial evaluates neoadjuvant stereotactic ablative radiotherapy targeting inferior vena cava tumor thrombus before nephrectomy and thrombectomy, including feasibility, safety, clinical outcomes, and exploratory biomarker analyses.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Checkpoint Inhibitors Plus Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors	0	4.57	01-09-2023
2	Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer	0	5	18-06-2026
3	Nivolumab-Ipilimumab for Gastric/Gastroesophageal Junction Adenocarcinoma	0	17.25	15-10-2026
4	Organ Preservation and QOL After Total Neoadjuvant Treatment in Rectal Cancer	0	7.94	15-10-2026
5	Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy	0	11.16	01-06-2024
6	Preoperative High-Dose Corticosteroids in Digestive Cancer Surgery	0	9.7	19-08-2026
7	Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer	0	8.64	01-08-2026
8	Chondroitin Sulfate Adhesion Barrier System in Open Rectal Resection	0	10.66	26-08-2026
9	Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer	0	10.24	01-07-2026
10	ASTRO updates guideline on radiation therapy for pancreatic cancer	0	7.3	13-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.27. Источник: www.jamanetwork.com.